Redoxis
- Other R&D services
- CMO, CRO
Redoxis is a Swedish preclinical CRO specializing in inflammation and autoimmune diseases. We offer customized in vitro and in vivo models for efficacy, mechanism-of-action, and product characterization studies—supporting early drug development across small molecules, biologics, cell and gene therapies, and mRNA platforms.